Royalty Pharma

RPRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$58.51

+$0.07 (+0.12%)

Sep 22, 2026, 2:09 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	2.38B	2.26B	2.35B	2.24B	2.29B	2.12B
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	2.38B	2.26B	2.35B	2.24B	2.29B	2.12B
Operating Income	1.56B	1.29B	1.49B	307.07M	1.43B	1.6B
Interest Income	33.59M	47.34M	72.29M	78.34M	53.54M	28.38M
Pretax Income	1.32B	1.33B	1.7B	230.06M	1.24B	1.7B
Net Income	770.95M	858.98M	1.13B	42.83M	619.73M	975.04M
Selling & General & Admin	573.48M	236.67M	249.75M	227.3M	182.83M	181.72M
Research & Development	452M	2M	52M	177.11M	200.08M	26.29M
Other Expenses	-206.81M	732.46M	560.66M	1.53B	475.84M	318.95M
Operating Expenses	818.68M	971.13M	862.4M	1.93B	858.75M	526.95M
Interest Expense	307.66M	225.51M	187.19M	187.96M	166.14M	157.06M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	818.68M	971.13M	862.4M	1.93B	858.75M	526.95M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	431.89M	445.99M	447.6M	437.96M	414.79M	388.14M
Shares Outstanding (Diluted)	559.61M	594M	602.9M	564.93M	414.8M	388.14M
EPS (Basic)	2.33	1.92	3.41	0.10	1.49	1.28
EPS (Diluted)	1.80	1.91	2.53	0.10	1.49	1.28
EBITDA	1.64B	1.56B	1.89B	423.7M	1.43B	1.88B
EBIT	1.63B	1.56B	1.89B	418.03M	1.41B	1.86B
Depreciation & Amortization	3.85M	n/a	n/a	5.67M	23M	23.06M